🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseEfinopegdutide MASH data — July 2024 Page 5

Efinopegdutide MASH data — July 2024

KarenAZ_mom Thu, May 30, 2024 at 2:14 PM 39 replies 2,830 viewsPage 5 of 8
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jun 14, 2024 at 11:50 PM#21

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

28 1JakeSmashed95, NauseaFreeNow, SteveThurs and 25 others
Reply Quote Save Share Report
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Jun 20, 2024 at 6:16 AM#22
Dr.NateNeph said:
The useful move here is to separate what is established from what is widely repeated.

Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.

29 2JenPlateau, SallyK_inj, CryptoCarl and 26 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Jun 25, 2024 at 12:39 PM#23
Dr.NateNeph said:
The useful move here is to separate what is established from what is widely repeated.

Coming at Dr.NateNeph’s question from a different direction. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

30 3FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 27 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
labquiet_amy
Senior Member
1,234
6,789
Mar 2024
Cambridge, MA
Jun 30, 2024 at 6:59 PM#24

The figures, for anyone assembling their own picture. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

31 4bri_stats, pete_manc_UK, anna.melb_AU and 28 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Jul 6, 2024 at 1:16 AM#25

One thing that is still open after Dr.NateNeph’s answer:

What did you change at the same time, and can you separate the two now?

Last edited: Jul 6, 2024 at 4:16 AM
32 5SleepFixSam, PurityPaulOR, MaxMetOK and 29 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register